NanoCellect Biomedical
Latest round
- Series D
Last raised
- Aug 2021
Total raised
- $47M
Investors
- 10
About NanoCellect Biomedical
Founded in 2009 in San Diego, US, NanoCellect Biomedical specializes in advanced cell sorting solutions. The founders include Jose Morachis, Nate Heintzman, Sunghwan Cho, William Alaynick, and Yu-Hwa Lo.NanoCellect Biomedical specializes in the development and provision of advanced microfluidic cell sorting technologies aimed at enhancing research across various fields, including stem cell research, plant biology, genomics, antibody discovery, cell line development, and gene editing. Their flagship products, such as the WOLF G2 Cell Sorter and VERLO Image-Guided Cell Sorter, utilize low-pressure microfluidic systems that operate at less than 2 psi, ensuring high cell viability and integrity during sorting. This technology allows for gentle handling of sensitive cell types, minimizing shear stress and ensuring clonal outgrowth without differentiation. The company primarily serves academic research institutions, biotechnology firms, and pharmaceutical companies seeking efficient and reliable cell sorting solutions.NanoCellect Biomedical generates revenue through direct sales of its cell sorting devices and associated consumables, including microfluidic cartridges and calibration beads. The company structures its transactions primarily through B2B channels, engaging directly with research labs and institutions, as well as establishing partnerships with distributors in various regions. Regular transactions may involve clients purchasing equipment such as the WOLF Cell Sorter, alongside essential consumables for ongoing operations, thereby creating a recurring revenue stream through repeat purchases.In August 2021, NanoCellect Biomedical, Inc. The company plans to expand its commercial go-to-market strategies to enhance its presence in existing and new markets, focusing on sectors that require sophisticated cell sorting technologies.
Who invested in NanoCellect Biomedical
10 investors across 4 rounds
See all investors in NanoCellect Biomedical
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about NanoCellect Biomedical
Who invested in NanoCellect Biomedical?
NanoCellect Biomedical has 10 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NanoCellect Biomedical raised?
NanoCellect Biomedical has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did NanoCellect Biomedical last raise money?
NanoCellect Biomedical's most recent round on record is a Series D, in Aug 2021.
What does NanoCellect Biomedical do?
Founded in 2009 in San Diego, US, NanoCellect Biomedical specializes in advanced cell sorting solutions.
Where is NanoCellect Biomedical headquartered?
NanoCellect Biomedical is headquartered in San Diego, US.
Which VCs invest in companies like NanoCellect Biomedical?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at NanoCellect Biomedical's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like NanoCellect Biomedical? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.